Multiple Myeloma

>

Latest News

Developments in CAR T-Cell and Bispecific Therapies in R/R Multiple Myeloma
Developments in CAR T-Cell and Bispecific Therapies in R/R Multiple Myeloma

February 22nd 2025

Hematology oncology experts discuss recent developments in CAR T-cell therapies as well as bispecific therapies for the treatment of patients with R/R MM.

Ide-Cel Yields High Response Rates in Post-Transplant Myeloma Patients
Ide-Cel Yields High Response Rates in Post-Transplant Myeloma Patients

February 17th 2025

OPN-6602 Granted Orphan Drug Designation in R/R Multiple Myeloma
OPN-6602 Granted Orphan Drug Designation in R/R Multiple Myeloma

February 16th 2025

Considering NCCN Guidelines to Determine Maintenance Therapy Multiple Myeloma
Considering NCCN Guidelines to Determine Maintenance Therapy Multiple Myeloma

February 15th 2025

Cilta-Cel Achieves High MRD Negativity Rates in Lenalidomide-Refractory Multiple Myeloma
Cilta-Cel Achieves High MRD Negativity Rates in Lenalidomide-Refractory Multiple Myeloma

February 15th 2025